Royalty Pharma and InNexus Biotechnology Announce Agreement Regarding the Purchase of a Second Royalty Right Based on InNexus' DXL(TM) Antibody Technology.
In: Business Wire, 2008-02-07
Zeitungsartikel
Zugriff:
Titel: |
Royalty Pharma and InNexus Biotechnology Announce Agreement Regarding the Purchase of a Second Royalty Right Based on InNexus' DXL(TM) Antibody Technology.
|
---|---|
Zeitschrift: | Business Wire, 2008-02-07 |
Veröffentlichung: | 2008 |
Medientyp: | Zeitungsartikel |
Sonstiges: |
|